Cite
HARVARD Citation
Venkata, P. et al. (2022). KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. Cancer letters. pp. 219-231. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Venkata, P. et al. (2022). KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer. Cancer letters. pp. 219-231. [Online].